Renaissance Investment Group’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.13M Hold
940
0.22% 43
2026
Q1
$865K Sell
940
-100
-10% -$101K 0.19% 48
2025
Q4
$1.12M Hold
1,040
0.23% 46
2025
Q3
$794K Hold
1,040
0.16% 52
2025
Q2
$811K Hold
1,040
0.18% 51
2025
Q1
$859K Hold
1,040
0.21% 51
2024
Q4
$803K Hold
1,040
0.17% 54
2024
Q3
$921K Hold
1,040
0.19% 55
2024
Q2
$970K Hold
1,040
0.21% 54
2024
Q1
$809K Sell
1,040
-200
-16% -$142K 0.19% 56
2023
Q4
$723K Hold
1,240
0.18% 56
2023
Q3
$666K Hold
1,240
0.19% 55
2023
Q2
$582K Buy
1,240
+40
+3% +$16.8K 0.15% 58
2023
Q1
$412K Hold
1,200
0.12% 64
2022
Q4
$439K Sell
1,200
-400
-25% -$142K 0.13% 62
2022
Q3
$557K Buy
+1,600
New +$507K 0.17% 60

Other funds holding LLY

Renaissance Investment Group's LLY Position: Q2 2026 in Review

Renaissance Investment Group held its Eli Lilly (LLY) position steady in Q2 2026 at 940 shares worth $1.13M. The position accounts for 0.22% of the portfolio, ranked #43.

Renaissance Investment Group first reported a position in LLY in Q3 2022 and has held it in 16 quarters since. 1,103 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Renaissance Investment Group held 940 shares of Eli Lilly worth $1.13M as of Q2 2026.
  • Renaissance Investment Group left its Eli Lilly share count unchanged in Q2 2026.
  • Eli Lilly made up 0.22% of Renaissance Investment Group's portfolio in Q2 2026, its #43 holding.
  • Renaissance Investment Group first reported a position in Eli Lilly in Q3 2022 and has held it in 16 quarters since.
  • 1,103 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Renaissance Investment Group's 13F filing for Q2 2026, filed 8 Jul 2026.